Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exelixis, Inc. - Common Stock (NQ:EXEL)

41.75 +0.16 (+0.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,943,999
Open 41.78
Bid (Size) 41.51 (2)
Ask (Size) 41.75 (1)
Prev. Close 41.59
Today's Range 41.52 - 42.07
52wk Range 21.36 - 48.85
Shares Outstanding 315,048,788
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EXELIXIS INC (NASDAQ:EXEL) – A Strong Growth Stock with Attractive Valuation
EXELIXIS INC (NASDAQ:EXEL) offers strong growth, solid profitability, and reasonable valuation, making it a compelling choice for investors seeking affordable growth stocks in the biotech sector. 
Via Chartmill
DoorDash To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga

Performance

YTD
+23.0%
+23.0%
1 Month
-8.0%
-8.0%
3 Month
+12.8%
+12.8%
6 Month
+15.7%
+15.7%
1 Year
+91.7%
+91.7%

More News

Read More
EXELIXIS INC (NASDAQ:EXEL) – A Strong Contender in Undervalued Biotech Stocks
Via Chartmill
EXELIXIS INC (NASDAQ:EXEL) – A High-Growth Momentum Stock with Strong Technical Setup
Via Chartmill
Analyst Expectations For Exelixis's Future
Via Benzinga
Price Over Earnings Overview: Exelixis
Via Benzinga
Exploring Exelixis's Earnings Expectations
Via Benzinga
EXELIXIS INC (NASDAQ:EXEL) – A Strong Growth Stock with Technical Breakout Potential
Via Chartmill
2 Top Stocks to Buy With Less Than $100
Via The Motley Fool
Exposures Product Safety
EXELIXIS INC (NASDAQ:EXEL) – A Strong Contender for Growth Investors
Via Chartmill
Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025
From Exelixis, Inc.
Via Business Wire
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May and June
From Exelixis, Inc.
Via Business Wire
EXELIXIS INC (NASDAQ:EXEL) – A Strong Growth Stock with Attractive Valuation
Via Chartmill
EXELIXIS INC (NASDAQ:EXEL) – An Undervalued Biotech Stock with Strong Fundamentals
Via Chartmill
CoreWeave, Super Micro Computer And Coinbase Are Among Top 11 Large-Cap Gainers Last Week (May 12-May 16): Are The Others In Your Portfolio?
Via Benzinga
EXELIXIS INC (NASDAQ:EXEL) – A Strong Contender in High Growth Momentum and Minervini’s Trend Template
Via Chartmill
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Demystifying Exelixis: Insights From 8 Analyst Reviews
Via Benzinga
Exelixis Stock Soars As Analysts Applaud Raised 2025 Guidance, Q1 Earnings Beat
Via Benzinga
Tech Stocks Edge Up, AMD Rallies 5%, 30-Year Yields Eye Danger Zone: What's Driving Markets Wednesday?
Via Benzinga
Why Exelixis Stock Is Skyrocketing Today
Via The Motley Fool
Exelixis Crushes Q1 Earnings Estimates With Strong Cabometyx Sales, Raises 2025 Revenue Guidance
Via Benzinga
Biotech Leader Exelixis Pops After Obliterating First-Quarter Profit Expectations
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Exelixis Announces First Quarter 2025 Financial Results and Provides Corporate Update
From Exelixis, Inc.
Via Business Wire
Earnings Scheduled For May 13, 2025
Via Benzinga

Frequently Asked Questions

Is Exelixis, Inc. - Common Stock publicly traded?
Yes, Exelixis, Inc. - Common Stock is publicly traded.
What exchange does Exelixis, Inc. - Common Stock trade on?
Exelixis, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exelixis, Inc. - Common Stock?
The ticker symbol for Exelixis, Inc. - Common Stock is EXEL on the Nasdaq Stock Market
What is the current price of Exelixis, Inc. - Common Stock?
The current price of Exelixis, Inc. - Common Stock is 41.75
When was Exelixis, Inc. - Common Stock last traded?
The last trade of Exelixis, Inc. - Common Stock was at 06/16/25 04:00 PM ET
What is the market capitalization of Exelixis, Inc. - Common Stock?
The market capitalization of Exelixis, Inc. - Common Stock is 13.15B
How many shares of Exelixis, Inc. - Common Stock are outstanding?
Exelixis, Inc. - Common Stock has 13B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.